Horizon Discovery is proud to announce that we are collaborating with YCharOS, Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, as members of YCharOS’s newly formed Industry Advisory Committee (IAC). The role of the IAC is to support YCharOS in realizing its purpose to enable users […]
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production […]
Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands — MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System for optical genome mapping (OGM) by WeHealth Shanghai, a leading provider of genome analysis services in reproductive health. The adoption was announced at the Structural Variation Symposium in Shanghai, organized with support from the Shanghai […]
Chicago/Boston — GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment. The companies aim to develop new artificial intelligence (AI)-powered […]
License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering Dublin, Ireland and Tokyo, Japan, 01 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents […]
Shoreline Biome’s microbiome products now available in the Nordics FARMINGTON, Conn.— Shoreline Biome, a leading microbiome company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a partnership with AH diagnostics A/S for product distribution. Shoreline Biome’s complete suite of products for use on the industry leading next […]
Global strategic alliance to leverage Sysmex’s Plasma-Safe-SeqS technology QIAGEN will use ultra-sensitive liquid biopsy applications in oncology Alliance boosts QIAGEN’s co-development of companion diagnostics with drug makers QIAGEN expects significant benefits for pharma companies and cancer patients worldwide Hilden, Germany, Germantown, Maryland, and Kobe, Japan – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced […]
Leatherhead, UK – Protein Stable and F-star Therapeutics have entered into a collaboration to explore the benefits of the high throughput SUPR-CM platform for early development, lead selection, formulation development and stability prediction. Jon Armer, Formulation Lead Senior Scientist at F-star commented: “At F-star, we are developing next generation tetravalent bispecifics for cancer immunotherapy which […]
Let’s Go Robotics and axiVEND announced today an agreement granting exclusive distribution rights to axiVEND for Precise Drop II and BioRaptr 2.0 products in the US commercial markets. Precise Drop II provides high performance and high precision micro-liquid dispensing at a lower cost. The product is highly configurable, making it easy to use in any environment […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
